Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Zain

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Dermatologic Clinics|October 5, 2015
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary SyndromePooja Virmani, Jasmine Zain, Steven T Rosen, et al.
JAAD Case Reports|July 14, 2021
Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rashNicholas A Trum, Jasmine Zain, Chelsea Abad, et al.
British Journal of Haematology|October 1, 2019
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg typeCosimo Di Raimondo, Farah R Abdulla, Jasmine Zain, et al.
JAAD Case Reports|March 20, 2026
Mogamulizumab-associated lymphadenopathy masquerading as lymphoma progressionParastou Tizro, Liliana Crisan, Karl Gaal, et al.
Oncology (Williston Park, N.Y.)|August 7, 2018
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCLNatalia Pin Chuen Zing, Thais Fischer, Jasmine Zain, et al.
Oncology (Williston Park, N.Y.)|August 29, 2018
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell LymphomaNatalia Pin Chuen Zing, Thais Fischer, Jasmine Zain, et al.
Pediatric Dermatology|April 24, 2020
Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patientBalaji Jothishankar, Cosimo Di Raimondo, Lisa Mueller, et al.
Blood Neoplasia|June 23, 2025
Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trialSwaminathan P Iyer, Shaker Dakhil, Michi M Shinohara, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2024
The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic IndicatorMonica Mead, Beth Glenn, Joe Tuscano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphomaLuca Paoluzzi, Luigi Scotto, Enrica Marchi, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Dermatologic Clinics|October 5, 2015
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary SyndromePooja Virmani, Jasmine Zain, Steven T Rosen, et al.
JAAD Case Reports|July 14, 2021
Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rashNicholas A Trum, Jasmine Zain, Chelsea Abad, et al.
British Journal of Haematology|October 1, 2019
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg typeCosimo Di Raimondo, Farah R Abdulla, Jasmine Zain, et al.
JAAD Case Reports|March 20, 2026
Mogamulizumab-associated lymphadenopathy masquerading as lymphoma progressionParastou Tizro, Liliana Crisan, Karl Gaal, et al.
Oncology (Williston Park, N.Y.)|August 7, 2018
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCLNatalia Pin Chuen Zing, Thais Fischer, Jasmine Zain, et al.
Oncology (Williston Park, N.Y.)|August 29, 2018
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell LymphomaNatalia Pin Chuen Zing, Thais Fischer, Jasmine Zain, et al.
Pediatric Dermatology|April 24, 2020
Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patientBalaji Jothishankar, Cosimo Di Raimondo, Lisa Mueller, et al.
Blood Neoplasia|June 23, 2025
Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trialSwaminathan P Iyer, Shaker Dakhil, Michi M Shinohara, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2024
The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic IndicatorMonica Mead, Beth Glenn, Joe Tuscano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphomaLuca Paoluzzi, Luigi Scotto, Enrica Marchi, et al.
Pageof 12